The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy

The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy

Abstract Background This retrospective study aimed to investigate whether the pretreatment hemoglobin-to-platelet ratio (HPR) could predict the risk of osteoradionecrosis (ORN) in patients receiving concurrent chemoradiotherapy (C-CRT) for locally advanced nasopharyngeal carcinoma (LA-NPC). Methods...

Full description

Bibliographic Details
Main Authors: Busra Yilmaz, Efsun Somay, Erkan Topkan, Ahmet Kucuk, Berrin Pehlivan, Ugur Selek
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Oral Health
Subjects:
Osteoradionecrosis
Nasopharyngeal cancer
Hemoglobin-to-platelet ratio
Concurrent chemoradiotherapy
Head and neck cancer
Online Access:https://doi.org/10.1186/s12903-023-02937-9

Similar Items

Similar Items